PRAMOMOLECULAR
PrivateCompany Overview
PRAMOMOLECULAR is a biotechnology company that develops self-delivering siRNAs as a new class of drugs to down-regulate disease-causing proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PRAMOMOLECULAR Comparables
Compare PRAMOMOLECULAR with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novartis | 76% | |
| Sanegene Bio | 74% | |
| Silexion Therapeutics Corp. | 74% |
PRAMOMOLECULAR Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors increased 1222% MoM, from 54 to 714.
PRAMOMOLECULAR Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PRAMOMOLECULAR's valuation, stock price, and market status.
Is PRAMOMOLECULAR a public or private company?
PRAMOMOLECULAR is a private company.
What is the current stock price of PRAMOMOLECULAR?
PRAMOMOLECULAR is a private company with no public stock price. No recent secondary market data is available.
How much is PRAMOMOLECULAR worth (valuation)?
Valuation information for PRAMOMOLECULAR is not publicly available.
Can I buy PRAMOMOLECULAR stock?
PRAMOMOLECULAR shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PRAMOMOLECULAR's last funding round?
Funding round information for PRAMOMOLECULAR is not publicly available.
Who are the main investors in PRAMOMOLECULAR?
Investor information for PRAMOMOLECULAR is not publicly disclosed.
Will PRAMOMOLECULAR IPO soon?
No public IPO plans have been announced for PRAMOMOLECULAR.
How can I track PRAMOMOLECULAR secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PRAMOMOLECULAR's secondary market activity and sign up for updates.